2024 Q2 Form 10-Q Financial Statement

#000121390024068952 Filed on August 14, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2023 Q4 2023 Q2
Revenue $2.329M $1.789M $7.284M
YoY Change -68.03% -97.81% -96.94%
Cost Of Revenue $2.543M $2.814M $7.394M
YoY Change -65.61% -95.95% -94.58%
Gross Profit -$214.0K -$1.025M -$110.0K
YoY Change 94.55% -108.41% -100.11%
Gross Profit Margin -9.19% -57.29% -1.51%
Selling, General & Admin $414.0K $492.0K $854.0K
YoY Change -51.52% -90.1% -99.26%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $919.0K $1.477M $1.674M
YoY Change -45.1% -87.81% -89.96%
% of Gross Profit
Operating Expenses $414.0K $492.0K $854.0K
YoY Change -51.52% -90.1% -99.29%
Operating Profit -$628.0K -$1.517M -$964.0K
YoY Change -34.85% -121.0% -95.08%
Interest Expense $9.000K $133.0K -$183.0K
YoY Change -104.92% -89.98% -102.43%
% of Operating Profit
Other Income/Expense, Net -$3.000K -$325.0K -$2.000K
YoY Change 50.0% -100.01%
Pretax Income -$704.0K -$1.709M -$1.115M
YoY Change -36.86% -125.62% -48.28%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$704.0K -$1.709M -$1.115M
YoY Change -36.86% -103.22% -84.63%
Net Earnings / Revenue -30.23% -95.53% -15.31%
Basic Earnings Per Share -$0.27 -$0.11
Diluted Earnings Per Share -$0.27 -$0.97 -$0.91
COMMON SHARES
Basic Shares Outstanding 2.611M shares 2.098M shares 1.286M shares
Diluted Shares Outstanding 2.611M shares 1.286M shares

Balance Sheet

Concept 2024 Q2 2023 Q4 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $287.0K $43.00K $215.0K
YoY Change 33.49% -87.09% -98.39%
Cash & Equivalents $287.0K $43.00K $215.0K
Short-Term Investments
Other Short-Term Assets $8.947M $436.0K $3.558M
YoY Change 151.46% -94.7% -97.52%
Inventory
Prepaid Expenses $2.285M
Receivables $441.0K $5.485M $5.485M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $9.675M $8.944M $9.258M
YoY Change 4.5% -36.37% -95.91%
LONG-TERM ASSETS
Property, Plant & Equipment $12.06M $12.70M $13.56M
YoY Change -11.01% -5.23% -90.94%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $2.922M $2.897M $2.886M
YoY Change 1.25% 0.42% -92.71%
Other Assets
YoY Change
Total Long-Term Assets $14.99M $15.60M $16.44M
YoY Change -8.86% -4.23% -96.62%
TOTAL ASSETS
Total Short-Term Assets $9.675M $8.944M $9.258M
Total Long-Term Assets $14.99M $15.60M $16.44M
Total Assets $24.66M $24.54M $25.70M
YoY Change -4.04% -19.12% -96.4%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $90.00K $128.0K $155.0K
YoY Change -41.94% -96.3% -98.7%
Accrued Expenses $50.00K
YoY Change -99.91%
Deferred Revenue $670.0K $792.0K
YoY Change
Short-Term Debt $510.0K $125.0K $453.0K
YoY Change 12.58% -97.92%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $5.069M $5.101M $658.0K
YoY Change 670.36% -53.9% -99.89%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $6.739M
YoY Change -92.57%
Total Long-Term Liabilities $0.00 $0.00 $6.739M
YoY Change -100.0% -92.57%
TOTAL LIABILITIES
Total Short-Term Liabilities $5.069M $5.101M $658.0K
Total Long-Term Liabilities $0.00 $0.00 $6.739M
Total Liabilities $5.069M $5.101M $7.397M
YoY Change -31.47% -53.9% -98.93%
SHAREHOLDERS EQUITY
Retained Earnings -$188.0M -$186.6M
YoY Change 1.54%
Common Stock $207.6M $206.0M
YoY Change 326949.21%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $19.59M $19.44M $18.30M
YoY Change
Total Liabilities & Shareholders Equity $24.66M $24.54M $25.70M
YoY Change -4.04% -19.12% -96.4%

Cashflow Statement

Concept 2024 Q2 2023 Q4 2023 Q2
OPERATING ACTIVITIES
Net Income -$704.0K -$1.709M -$1.115M
YoY Change -36.86% -103.22% -84.63%
Depreciation, Depletion And Amortization $919.0K $1.477M $1.674M
YoY Change -45.1% -87.81% -89.96%
Cash From Operating Activities $3.497M $1.397M $2.411M
YoY Change 45.04% -101.77% -101.78%
INVESTING ACTIVITIES
Capital Expenditures $3.420M $674.0K $1.827M
YoY Change 87.19% -129.78% -97.12%
Acquisitions
YoY Change
Other Investing Activities -$24.00K -$2.119M $0.00
YoY Change -86.12% -100.0%
Cash From Investing Activities -$3.444M -$2.793M -$1.827M
YoY Change 88.51% -78.52% -43.66%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 202.0K 1.224M -417.0K
YoY Change -148.44% -98.14% -96.62%
NET CHANGE
Cash From Operating Activities 3.497M 1.397M 2.411M
Cash From Investing Activities -3.444M -2.793M -1.827M
Cash From Financing Activities 202.0K 1.224M -417.0K
Net Change In Cash 255.0K -172.0K 167.0K
YoY Change 52.69% -99.34% -100.11%
FREE CASH FLOW
Cash From Operating Activities $3.497M $1.397M $2.411M
Capital Expenditures $3.420M $674.0K $1.827M
Free Cash Flow $77.00K $723.0K $584.0K
YoY Change -86.82% -100.94% -100.29%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Address Address Line1
EntityAddressAddressLine1
1306, 13th Floor
dei Entity Address Address Line2
EntityAddressAddressLine2
Xuesong Dasha Building B
dei Entity Address City Or Town
EntityAddressCityOrTown
Shenzhen
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
518000
dei Entity Address Country
EntityAddressCountry
CN
dei City Area Code
CityAreaCode
+86
dei Local Phone Number
LocalPhoneNumber
86 755 8255 5262
dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
2610785 shares
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
43000 usd
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
287000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5485000 usd
CY2024Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
441000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2980000 usd
CY2024Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
8132000 usd
CY2023Q4 us-gaap Crypto Asset Fair Value Current
CryptoAssetFairValueCurrent
436000 usd
CY2024Q2 us-gaap Crypto Asset Fair Value Current
CryptoAssetFairValueCurrent
815000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
8944000 usd
CY2024Q2 us-gaap Assets Current
AssetsCurrent
9675000 usd
CY2023Q4 us-gaap Equity Method Investments
EquityMethodInvestments
2897000 usd
CY2024Q2 us-gaap Equity Method Investments
EquityMethodInvestments
2922000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
12702000 usd
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
12064000 usd
CY2023Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
15599000 usd
CY2024Q2 us-gaap Assets Noncurrent
AssetsNoncurrent
14986000 usd
CY2023Q4 us-gaap Assets
Assets
24543000 usd
CY2024Q2 us-gaap Assets
Assets
24661000 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
128000 usd
CY2024Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
90000 usd
CY2023Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
125000 usd
CY2024Q2 us-gaap Short Term Borrowings
ShortTermBorrowings
510000 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
792000 usd
CY2024Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
670000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5101000 usd
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
5069000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
5101000 usd
CY2024Q2 us-gaap Liabilities
Liabilities
5069000 usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.06
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.06
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000000 shares
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2097535 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2097535 shares
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2610785 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2610785 shares
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
121000 usd
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
139000 usd
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
205920000 usd
CY2024Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
207487000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-186599000 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-188034000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
19442000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
19592000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
19442000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
19592000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
24543000 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
24661000 usd
CY2023Q2 us-gaap Revenues
Revenues
6377000 usd
CY2024Q2 us-gaap Revenues
Revenues
2329000 usd
us-gaap Revenues
Revenues
7284000 usd
us-gaap Revenues
Revenues
4979000 usd
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
6144000 usd
CY2024Q2 us-gaap Cost Of Revenue
CostOfRevenue
2543000 usd
us-gaap Cost Of Revenue
CostOfRevenue
7394000 usd
us-gaap Cost Of Revenue
CostOfRevenue
5321000 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
233000 usd
CY2024Q2 us-gaap Gross Profit
GrossProfit
-214000 usd
us-gaap Gross Profit
GrossProfit
-110000 usd
us-gaap Gross Profit
GrossProfit
-342000 usd
CY2023Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
70000 usd
CY2024Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
61000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
198000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
96000 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
262000 usd
CY2024Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
353000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
791000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1259000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-99000 usd
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-628000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-1099000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-1697000 usd
CY2023Q2 us-gaap Crypto Asset Realized Gain Loss Nonoperating
CryptoAssetRealizedGainLossNonoperating
-17000 usd
CY2024Q2 us-gaap Crypto Asset Realized Gain Loss Nonoperating
CryptoAssetRealizedGainLossNonoperating
-74000 usd
us-gaap Crypto Asset Realized Gain Loss Nonoperating
CryptoAssetRealizedGainLossNonoperating
34000 usd
us-gaap Crypto Asset Realized Gain Loss Nonoperating
CryptoAssetRealizedGainLossNonoperating
256000 usd
CY2023Q2 us-gaap Interest Income Other
InterestIncomeOther
1000 usd
us-gaap Interest Income Other
InterestIncomeOther
1000 usd
CY2023Q2 us-gaap Interest Expense
InterestExpense
20000 usd
CY2024Q2 us-gaap Interest Expense
InterestExpense
9000 usd
us-gaap Interest Expense
InterestExpense
50000 usd
us-gaap Interest Expense
InterestExpense
15000 usd
CY2023Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1000 usd
CY2024Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
10000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
25000 usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1000 usd
CY2024Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-4000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-135000 usd
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-704000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1115000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1435000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-135000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-704000 usd
us-gaap Net Income Loss
NetIncomeLoss
-1115000 usd
us-gaap Net Income Loss
NetIncomeLoss
-1435000 usd
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.11
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.27
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.91
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.56
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.11
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.27
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.91
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.56
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1285549 shares
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2610785 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1229652 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2577607 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1285549 shares
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2610785 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1229652 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2577607 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
19280000 usd
us-gaap Net Income Loss
NetIncomeLoss
-1115000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
138000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
18303000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
19442000 usd
us-gaap Net Income Loss
NetIncomeLoss
-1435000 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1014000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
571000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
19592000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
18300000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-135000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
138000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
18303000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
20296000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-704000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
19592000 usd
us-gaap Net Income Loss
NetIncomeLoss
-1115000 usd
us-gaap Net Income Loss
NetIncomeLoss
-1435000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1674000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1781000 usd
us-gaap Crypto Asset Realized Gain Loss Nonoperating
CryptoAssetRealizedGainLossNonoperating
34000 usd
us-gaap Crypto Asset Realized Gain Loss Nonoperating
CryptoAssetRealizedGainLossNonoperating
256000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
25000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
138000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
571000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-3417000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-5044000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1531000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2270000 usd
btct Increase Decrease In Change Of Crypto Assets
IncreaseDecreaseInChangeOfCryptoAssets
-51000 usd
btct Increase Decrease In Change Of Crypto Assets
IncreaseDecreaseInChangeOfCryptoAssets
123000 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
50000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-3300000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-38000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
420000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2411000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
3669000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1827000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4025000 usd
us-gaap Payments For Advance To Affiliate
PaymentsForAdvanceToAffiliate
647000 usd
us-gaap Proceeds From Collection Of Advance To Affiliate
ProceedsFromCollectionOfAdvanceToAffiliate
390000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1827000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4282000 usd
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
721000 usd
us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
417000 usd
us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
336000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
472000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-417000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
857000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
167000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
244000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
48000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
43000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
215000 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
287000 usd
us-gaap Interest Paid Net
InterestPaidNet
50000 usd
us-gaap Interest Paid Net
InterestPaidNet
15000 usd
CY2019Q3 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
1000 shares
CY2020Q1 btct Issued And Outstanding Percentage
IssuedAndOutstandingPercentage
1 pure
us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.1519 pure
us-gaap Stock Issued During Period Shares Stock Splits
StockIssuedDuringPeriodSharesStockSplits
48391607 shares
CY2020Q1 us-gaap Investment Company Committed Capital
InvestmentCompanyCommittedCapital
4000 usd
CY2020Q1 us-gaap Investment Company Committed Capital
InvestmentCompanyCommittedCapital
6000 usd
CY2020Q1 btct Investment Finance Cost
InvestmentFinanceCost
12000 usd
btct Investment Termination Cost
InvestmentTerminationCost
4000 usd
CY2017Q4 us-gaap Stock Or Units Available For Distributions
StockOrUnitsAvailableForDistributions
30000000 shares
CY2017Q4 us-gaap Stock Issued1
StockIssued1
1 cny
us-gaap Distribution Made To Limited Partner Cash Distributions Paid
DistributionMadeToLimitedPartnerCashDistributionsPaid
148270000 cny
us-gaap Use Of Estimates
UseOfEstimates
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(a)</i></b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Use of estimates</i></b></span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The preparation of the Company’s consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the balance sheet date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant items subject to such estimates and assumptions include, but are not limited to, estimate of standalone selling prices of each unit of accounting in multiple elements arrangements, estimate of breakage, the fair value of identifiable assets acquired, liabilities assumed and non-controlling interests in business combinations, the useful lives of long-lived assets including intangible assets, the fair value of the reporting unit for the goodwill impairment test, the allowance for doubtful accounts receivable and other receivables, the realization of deferred tax assets, the fair value of share-based compensation awards, lease liabilities, right-of-use assets and the recoverability of long-lived assets. Changes in facts and circumstances may result in revised estimates. Actual results could differ from those estimates, and as such, differences may be material to the consolidated financial statements.</p>
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5485000 usd
CY2024Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
441000 usd
CY2023Q4 btct Prepayment For Equipment Current
PrepaymentForEquipmentCurrent
2285000 usd
CY2024Q2 btct Prepayment For Equipment Current
PrepaymentForEquipmentCurrent
7463000 usd
CY2023Q4 us-gaap Deposits Assets Current
DepositsAssetsCurrent
328000 usd
CY2024Q2 us-gaap Deposits Assets Current
DepositsAssetsCurrent
328000 usd
CY2023Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
367000 usd
CY2024Q2 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
341000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2980000 usd
CY2024Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
8132000 usd
CY2023Q4 us-gaap Crypto Asset Fair Value Current
CryptoAssetFairValueCurrent
436000 usd
CY2024Q2 us-gaap Crypto Asset Fair Value Current
CryptoAssetFairValueCurrent
815000 usd
CY2022Q4 us-gaap Crypto Asset Fair Value
CryptoAssetFairValue
91000 usd
CY2023Q4 us-gaap Crypto Asset Fair Value
CryptoAssetFairValue
436000 usd
CY2023 us-gaap Crypto Asset Mining
CryptoAssetMining
2882000 usd
us-gaap Crypto Asset Mining
CryptoAssetMining
939000 usd
CY2023 btct Exchange Of Cryptocurrency
ExchangeOfCryptocurrency
-2537000 usd
btct Exchange Of Cryptocurrency
ExchangeOfCryptocurrency
-560000 usd
CY2023Q4 us-gaap Crypto Asset Fair Value
CryptoAssetFairValue
436000 usd
CY2024Q2 us-gaap Crypto Asset Fair Value
CryptoAssetFairValue
815000 usd
CY2022Q4 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
0.06
CY2022Q4 us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
7120478000 cny
us-gaap Equity Method Investment Deferred Gain On Sale
EquityMethodInvestmentDeferredGainOnSale
1000000 usd
us-gaap Equity Method Investment Deferred Gain On Sale
EquityMethodInvestmentDeferredGainOnSale
25000000 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
17241000 usd
CY2024Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
18384000 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4539000 usd
CY2024Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
6320000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
12702000 usd
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
12064000 usd
us-gaap Depreciation
Depreciation
1674 usd
us-gaap Depreciation
Depreciation
1781 usd
us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0.0825 pure
CY2023Q4 btct Loans Pledged As Collateral Amount
LoansPledgedAsCollateralAmount
4.09
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-135000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-704000 usd
us-gaap Net Income Loss
NetIncomeLoss
-1115000 usd
us-gaap Net Income Loss
NetIncomeLoss
-1435000 usd
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1285549 shares
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2610785 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1229652 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2577607 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1285549 shares
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2610785 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1229652 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2577607 shares
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.11
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.27
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.91
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.56
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.11
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.27
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.91
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.56
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
138000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
571000 usd
CY2018Q3 btct Authorized Share Capital
AuthorizedShareCapital
380000 hkd
CY2018Q3 us-gaap Common Unit Authorized
CommonUnitAuthorized
38000000 shares
CY2018Q3 us-gaap Share Price
SharePrice
0.01
CY2018Q4 us-gaap Common Unit Issued
CommonUnitIssued
318601222 shares
CY2018Q4 us-gaap Share Price
SharePrice
0.0001
CY2018Q4 us-gaap Stock Repurchase Program Remaining Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased
47035 shares
CY2018Q4 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
0.01
CY2020Q1 us-gaap Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
48391607 shares
CY2020Q1 us-gaap Investment Company Committed Capital
InvestmentCompanyCommittedCapital
6000 usd
CY2020Q1 us-gaap Investment Company Committed Capital
InvestmentCompanyCommittedCapital
4000 usd
CY2020Q1 us-gaap Investment Company Committed Capital
InvestmentCompanyCommittedCapital
6000 usd
CY2020Q2 btct Investment Termination Cost
InvestmentTerminationCost
4000 usd
CY2020Q1 us-gaap Shares Outstanding
SharesOutstanding
3050701 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Percentage Of Outstanding Stock Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum
0.01 pure
CY2024Q2 btct Ordinary Share Issued
OrdinaryShareIssued
531005 shares
btct Additional Share Based Compensation Arrangement By Share Based Payment Award Percentage Of Outstanding Stock Maximum
AdditionalShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum
0.01 pure
CY2021Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
22500000 shares
CY2021Q3 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
0.3
CY2021Q4 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
33333334 shares
CY2021Q4 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
0.6
CY2022Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
1470475 shares
CY2022Q3 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
0.3
CY2022Q4 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
3532841 shares
CY2022Q4 us-gaap Common Unit Issuance Value
CommonUnitIssuanceValue
7120478000 cny
CY2023Q3 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
1000000 usd
CY2023Q3 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
5
CY2023Q3 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
0.06
CY2024Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
303497 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2097535 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2097535 shares
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2610785 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2610785 shares
CY2020Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
12705000 shares
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
6192286.8 usd
btct Warrants To Purchase Ordinary Shares
WarrantsToPurchaseOrdinaryShares
2629812 shares
us-gaap Warrant Exercise Price Increase
WarrantExercisePriceIncrease
1.4
CY2024Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
11.5
btct Warrants Outstanding Percentage
WarrantsOutstandingPercentage
0.555 pure
btct Net Proceed From Issuance Of Warrant
NetProceedFromIssuanceOfWarrant
5730000 usd
CY2021Q1 btct Warrants To Purchase Ordinary Shares
WarrantsToPurchaseOrdinaryShares
336001 shares
CY2021Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
2.5
CY2021Q3 btct Warrants To Purchase Ordinary Shares
WarrantsToPurchaseOrdinaryShares
177500000 shares
CY2021Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.0001
CY2021Q3 btct Beneficially Owned Percentage
BeneficiallyOwnedPercentage
0.0499 pure
CY2021Q3 btct Share Outstanding Percentage
ShareOutstandingPercentage
0.0999 pure
us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
the Company became exercisable for 1/30 ordinary share of the Company, and the exercise price of Company’s outstanding warrants was increased to US$9.00, adjusted from $0.30 prior to the Reverse Split and representing the temporarily reduced price based on the Company’s Tender Offer Statement on Schedule TO, as amended and supplemented, originally filed by the Company with the U.S. Securities and Exchange Commission on December 7, 2020 (the “Tender Offer”). Based on the terms of the Tender Offer, following the date on which the closing price of the Company’s ordinary shares has been equal to or greater than $90.00 per share for at least twenty (20) trading days during the preceding thirty (30) trading day period, the exercise price of the Company’s outstanding warrants would be increased to US$345.00.
btct Ordinary Shares Description
OrdinarySharesDescription
the Company offered 22,899,047 ordinary shares, par value US$0.003 per share, consisting of (a) 1,470,475 ordinary shares issuable upon the exercise of pre-funded warrants (the “Pre-Funded Warrants”) and (b) 21,428,572 ordinary shares issuable upon the exercise of investor warrants (the “Investor Warrants”). Each Pre-Funded Warrant is exercisable for $0.001 per ordinary share and may be exercised at any time until all the Pre-Funded Warrants are exercised in full; and each Investor Warrant has an exercise price of $0.70 per share, is exercisable on or after August 8, 2022 and will expire on August 9, 2027.
us-gaap Proceeds From Collection Of Advance To Affiliate
ProceedsFromCollectionOfAdvanceToAffiliate
390000 usd
us-gaap Payments For Advance To Affiliate
PaymentsForAdvanceToAffiliate
647000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
4290000 usd
CY2024Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q2 us-gaap Interest Income Other
InterestIncomeOther
usd
us-gaap Interest Income Other
InterestIncomeOther
usd
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
usd
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
usd
CY2024Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
usd
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
usd
us-gaap Payments For Advance To Affiliate
PaymentsForAdvanceToAffiliate
usd
us-gaap Proceeds From Collection Of Advance To Affiliate
ProceedsFromCollectionOfAdvanceToAffiliate
usd
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
usd
CY2020Q1 us-gaap Investment Company Committed Capital
InvestmentCompanyCommittedCapital
6000 usd
CY2023Q2 us-gaap Amount Of Dilutive Securities Stock Options And Restrictive Stock Units
AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnits
usd
CY2024Q2 us-gaap Amount Of Dilutive Securities Stock Options And Restrictive Stock Units
AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnits
usd
us-gaap Amount Of Dilutive Securities Stock Options And Restrictive Stock Units
AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnits
usd
us-gaap Amount Of Dilutive Securities Stock Options And Restrictive Stock Units
AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnits
usd
us-gaap Proceeds From Collection Of Advance To Affiliate
ProceedsFromCollectionOfAdvanceToAffiliate
usd
us-gaap Payments For Advance To Affiliate
PaymentsForAdvanceToAffiliate
usd
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Central Index Key
EntityCentralIndexKey
0001796514

Files In Submission

Name View Source Status
0001213900-24-068952-index-headers.html Edgar Link pending
0001213900-24-068952-index.html Edgar Link pending
0001213900-24-068952.txt Edgar Link pending
0001213900-24-068952-xbrl.zip Edgar Link pending
btct-20240630.xsd Edgar Link pending
ea0210907-10q_btcdigital.htm Edgar Link pending
ea021090701ex31-1_btcdigital.htm Edgar Link pending
ea021090701ex31-2_btcdigital.htm Edgar Link pending
ea021090701ex32-1_btcdigital.htm Edgar Link pending
ea021090701ex32-2_btcdigital.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
btct-20240630_def.xml Edgar Link unprocessable
btct-20240630_lab.xml Edgar Link unprocessable
btct-20240630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
ea0210907-10q_btcdigital_htm.xml Edgar Link completed
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
btct-20240630_cal.xml Edgar Link unprocessable